Rapamycin and Torin2 inhibit Candida auris TOR: Insights through growth profiling, docking, and MD simulations
- 20 October 2022
- journal article
- research article
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 41 (17) , 8445-8461
Abstract
The fungus Candida auris is a pathogen of utmost concern due to its rapid emergence across the globe, acquired antifungal drug tolerance, thermotolerance, and ability to survive in hospital settings and preserved foods. Recent incidences of comorbidity of corona patients with its infection in hospital settings highlighted the importance of understanding the pathobiology and drug tolerance of this fungus on priority. The Target of rapamycin (TOR) is a central regulator of growth across eukaryotes with an illustrated role in fungal pathology. The role of the TOR signalling pathway in the growth of C. auris is yet to be described. In-silico, analysis revealed the presence of highly conserved Tor kinase, components of TORC, and key downstream components in C. auris. Rapamycin and Torin2, the specific inhibitors of Tor reduce the growth of C. auris. An inhibition of Tor leads to cell cycle arrest at the G1 phase with a defect in cytokinesis. Interestingly, with an insignificant difference in growth at 30 and 37 °C, a sharp decline in growth is seen with Torin2 at 37 °C. The heterogeneous response emphasizes the importance of physiology-based differential cellular response at different temperatures. In addition, the inhibition of Tor suppresses the biofilm formation. In silico studies through docking and simulations showed rapamycin and torin2 as specific inhibitors of C. auris Tor kinase (CauTor kinase) and hence can be exploited for a thorough understanding of the TOR signalling pathway in pathobiology and drug tolerance of C. auris. Communicated by Ramaswamy H. SarmaKeywords
Funding Information
- Regional Centre for Biotechnology
- Anusandhan National Research Foundation
This publication has 46 references indexed in Scilit:
- TORC1 signaling inhibition by rapamycin and caffeine affect lifespan, global gene expression, and cell proliferation of fission yeastAging Cell, 2013
- Cell Polarization and Cytokinesis in Budding YeastGenetics, 2012
- First Three Reported Cases of Nosocomial Fungemia Caused by Candida aurisJournal of Clinical Microbiology, 2011
- Discovery of 9-(6-Aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a Potent, Selective, and Orally Available Mammalian Target of Rapamycin (mTOR) Inhibitor for Treatment of CancerJournal of Medicinal Chemistry, 2011
- Mds3 Regulates Morphogenesis in Candida albicans through the TOR PathwayMolecular and Cellular Biology, 2010
- The Protein Kinase Tor1 Regulates Adhesin Gene Expression in Candida albicansPLOS Pathogens, 2009
- Candida aurissp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospitalMicrobiology and Immunology, 2009
- Stress and mTORture signalingOncogene, 2006
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Mammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast.Genes & Development, 1996